Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-06-26

→

Cover Story | Solving the Challenge of Deep Hypothermic Brain Protection: Unveiling a Novel Mechanism of White Matter Injury

This study not only fills a critical mechanistic gap in the field of hypothermic brain protection but also provides precise therapeutic targets for the prevention and treatment of white matter injury after complex congenital heart surgery.

2026-06-26

→

《Science》: Hyaluronic Acid and Tissue Mechanics Synergistically Regulate Mammalian Digit Tip Regeneration

This work was completed by scholars including Mui, Wong, and Storer from the University of Cambridge. In the same issue, Science also published a related study on oxygen-sensing regulation of limb regeneration, collectively providing important breakthroughs in understanding the mechanisms of mammalian regeneration.

2026-06-22

→

Novel Strategy for Cell Cryopreservation: Pre-Dehydration via Droplet Vacuum Evaporation

This approach holds broad application prospects in regenerative medicine (e.g., stem cell transplantation and organoid transplantation), drug screening (preservation of high‑throughput cell models), and biobanking (long‑term storage of rare cell resources).

2026-06-22

→

Cell Cover: Atlas of Human Cellular Senescence Unveiled, Ushering in the Era of Precision Anti-Aging

Professor Rong Fan, Executive Director of the SenNet consortium, remarked: “This atlas allows us, for the first time, to see the true distribution and diversity of senescent cells within the human body.” The consortium has made all data openly accessible at https://data.sennetconsortium.org for researchers worldwide. Industry experts believe this achievement will shift the medical paradigm from “treating disease after onset” to “pre‑identifying and eliminating harmful senescent cells,” with promising breakthroughs expected in neurodegenerative diseases, fibrotic liver disease, chronic wounds, and metabolic syndrome.

2026-06-12

→

World’s First “Reverse Aging” Gene Therapy Completes First Human Injection

In addition to eye diseases, Life Biosciences is exploring the potential of “partial reprogramming” for conditions such as liver fibrosis. If this trial confirms its safety and feasibility, it could open an entirely new path for anti-aging medicine—shifting from passively managing age-related diseases to actively reversing the aging process at the cellular level.

2026-06-12

→

Blocking "Xenophagocytosis": A Key Step Toward Growing Human Organs in Animals

Experts in the field believe that this study has found the key to protecting cross-species cells from early immune system clearance, opening a new door for regenerative medicine.